The Supreme Court heard the Biden administration’s objections to the bankruptcy plan filed by opioid manufacturer Purdue Pharma, which includes a controversial settlement that would shield the company’s founding family from future opioid-related liability.
The government argued that opioid victims could be shortchanged if the settlement is allowed to stand, a claim the company denied. The Biden administration said in court papers that the settlement as currently constituted would provide “a roadmap for corporations and wealthy individuals to misuse the bankruptcy system to avoid mass-tort liability.”